0-14岁诊断为1型糖尿病个体中度和重度白蛋白尿的发病率模式、累积发病率及时间趋势:一项基于人群的回顾性队列研究
发现1970-79与1980-89诊断队列间重度白蛋白尿累积发病率约减半(HR 0.55,95%CI 0.42-0.72,p<0.0001),但1980-89与1990-99队列间无进一步下降(HR 0.83,95%CI 0.54-1.26,p=0.38);中度白蛋白尿无日历年代效应(HR 0.99,95%CI 0.78-1.28,p=0.97)。
要点
- 1970-79至1980-89诊断队列重度白蛋白尿累积发病率约减半(HR 0.55,95%CI 0.42-0.72,p<0.0001)。
- 1980-89与1990-99队列间重度白蛋白尿无进一步下降(HR 0.83,95%CI 0.54-1.26,p=0.38)。
- 中度白蛋白尿在1980-89与1990-99队列间无日历年代效应(HR 0.99,95%CI 0.78-1.28,p=0.97)。
核心结论
- 1970-79至1980-99诊断队列间重度白蛋白尿累积发病率下降,但该下降是仅代表白蛋白尿延迟还是真正预防白蛋白尿需进一步研究。
- 糖尿病肾病仍是1型糖尿病的重要并发症,因与早发死亡robust相关,需要新疗法改善预后。
研究设计与样本
- 回顾性队列研究,随访至死亡、中度或重度白蛋白尿或肾衰竭事件、或最近无事件日期,系统回顾截至2020年12月31日的病历。
- 按糖尿病诊断日历年分为1970-79、1980-89、1990-99队列;采用广义可加模型评估病程特异性发病率模式,Kaplan-Meier分析计算累积发病率,以肾衰竭为终点时纳入死亡竞争风险。
主要发现
- 1970-79队列中重度白蛋白尿发病率在糖尿病病程15-19年出现峰值,该峰值在较晚诊断队列中未重现;1980-99合并队列中,发病率在病程前14年上升后进入平台期。
- 1970-79与1980-89队列间重度白蛋白尿累积发病率约减半(HR 0.55,95%CI 0.42-0.72,以1970-79队列为参照,p<0.0001);1980-89与1990-99队列间无进一步下降(HR 0.83,95%CI 0.54-1.26,以1980-89队列为参照,p=0.38)。
- 重度白蛋白尿25年累积发病率:1970-79队列26.8%(95%CI 22.6-30.8),1980-89队列12.0%(95%CI 9.0-15.0),1990-99队列10.8%(95%CI 6.7-14.6)。
- 重度白蛋白尿发病后15年进展至肾衰竭的累积进展率:1970-79队列35.2%(95%CI 27.4-43.0),1980-99合并队列35.6%(95%CI 24.3-47.0)(Gray检验p=0.37)。
- 中度白蛋白尿(1980-89和1990-99队列)累积发病率无日历年代效应(HR 0.99,95%CI 0.78-1.28,以1980-89队列为参照,p=0.97);其发病率在病程10年内上升,之后基本稳定,约25年后开始下降。
关键数值与推荐
- 中度及重度白蛋白尿基于国际参考限值分类(连续三次尿样中两次达到)。
- 肾衰竭定义为透析治疗或肾移植。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence and temporal trends of moderate and severe albuminuria during recent decades are poorly described in type 1 diabetes. We aimed to assess diabetes duration-specific incidence rates, cumulative incidence, and secular trends of albuminuria in type 1 diabetes in Finland. METHODS: We conducted a population-based, retrospective cohort study of a stratified random sample (n=1500) of all individuals diagnosed with type 1 diabetes before age 15 years during 1970-99 in Finland. The sampling frame was the database of the Finnish Institute for Health and Welfare. Individuals with an atypical clinical course, presentation of non-diabetic kidney disease, insufficient albumin excretion rate measurements, or unavailable medical records were excluded (final sample n=1430). Study participants were followed up until death, the event of interest (moderate or severe albuminuria or kidney failure), or the most recent event-free date. Medical records retrieved up to Dec 31, 2020 were systematically reviewed for albuminuria determinations. Moderate and severe albuminuria were categorised on the basis of international reference limits (two of three consecutive urine samples). Kidney failure was defined as dialysis treatment or kidney transplant. Cohorts defined by calendar year of diabetes diagnosis (1970-79, 1980-89, and 1990-99) were assessed. Patterns of duration-specific incidences were evaluated by fitting generalised additive models to the data, which were split into multiple observations of half-year duration. Cumulative incidences were calculated with Kaplan-Meier analysis. In analyses with kidney failure as the endpoint, competing risk for mortality was incorporated. FINDINGS: In our stratified random sample, 462 individuals were diagnosed with diabetes in 1970-79, 481 were diagnosed in 1980-89, and 487 were diagnosed in 1990-99. The incidence rate pattern of severe albuminuria changed over time; a peak at 15-19 years since diabetes onset in the 1970-79 cohort was not replicated in those diagnosed later. In the combined 1980-99 diagnosis-year cohorts, the incidence rate rose during the first 14 years after diabetes onset, after which it levelled off to a plateau. Between the 1970-79 and 1980-89 diabetes diagnosis cohorts, the cumulative incidence of severe albuminuria had approximately halved (hazard ratio [HR] 0·55 [95% CI 0·42-0·72] with the 1970-79 cohort as reference, p<0·0001), whereas, between the 1980-89 and 1990-99 cohorts, no further decrease was observed (HR 0·83 [0·54-1·26] with the 1980-89 cohort as reference, p=0·38). The 25-year cumulative incidence for severe albuminuria was 26·8% (22·6-30·8) in the 1970-79 diagnosis cohort, 12·0% (9·0-15·0) in the 1980-89 cohort, and 10·8% (6·7-14·6) in the 1990-99 cohort. 15 years after onset of severe albuminuria, cumulative progression rate from severe albuminuria to kidney failure was 35·2% (27·4-43·0) in the 1970-79 cohort and 35·6% (24·3-47·0) in the 1980-99 cohorts combined (Gray's test p=0·37). In the cohorts with data on moderate albuminuria (1980-89 and 1990-99), cumulative incidence of moderate albuminuria showed no calendar effect between the earlier and later cohorts (HR 0·99 [0·78-1·28] with the 1980-89 cohort as reference, p=0·97). The incidence rate of moderate albuminuria increased until 10 years after diabetes onset, then remained mostly stable until starting to decrease at around 25 years after diabetes onset. INTERPRETATION: Our analyses show that the cumulative incidence of severe albuminuria has decreased between 1970-79 and 1980-99; however, whether this decrease solely denotes a delay in albuminuria, or also a true prevention of albuminuria, needs to be investigated further. Nevertheless, diabetic kidney disease remains a significant complication of type 1 diabetes. Due to the robust association of diabetic kidney disease with premature mortality, novel therapies to improve prognosis are needed. FUNDING: Folkhälsan Research Foundation, Medical Society of Finland, Wilhelm and Else Stockmann Foundation, Finnish Diabetes Research Foundation, Waldemar von Frenckell Foundation, Liv och Hälsa Society, Academy of Finland, and Novo Nordisk Foundation. TRANSLATIONS: For the Finnish and Swedish translations of the abstract see Supplementary Materials section.
引用
- Jansson Sigfrids F, Groop PH, Harjutsalo V, et al. Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0-14 years: a population-based retrospective cohort study. Lancet Diabetes Endocrinol. 2022. PMID: 35489369. doi:10.1016/S2213-8587(22)00099-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。